Detalhe da pesquisa
1.
A comparison of tiotropium, long-acting ß2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma.
Respir Res
; 21(1): 19, 2020 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31931792
2.
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.
Respir Res
; 21(1): 240, 2020 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32943047
3.
Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5.
Pulm Pharmacol Ther
; 60: 101881, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31874283
4.
A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.
Int J Chron Obstruct Pulmon Dis
; 17: 545-558, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35309285
5.
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.
NPJ Prim Care Respir Med
; 32(1): 18, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618739
6.
Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses.
Adv Ther
; 38(2): 835-853, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306188
7.
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database.
Adv Ther
; 38(5): 2249-2270, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721209
8.
TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow.
Int J Chron Obstruct Pulmon Dis
; 16: 2455-2465, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34511891
9.
Impact of the UK lockdown on people at risk of COPD.
ERJ Open Res
; 7(4)2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820444
10.
Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study).
Pulm Ther
; 7(2): 591-606, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34533772
11.
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO® Trials.
Adv Ther
; 38(1): 579-593, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33175291
12.
No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD.
Int J Chron Obstruct Pulmon Dis
; 15: 1945-1953, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32848380
13.
A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD.
Int J Chron Obstruct Pulmon Dis
; 15: 1955-1965, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32848381
14.
Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials.
Adv Ther
; 37(10): 4175-4189, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32671684
15.
Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies.
Adv Ther
; 37(8): 3485-3499, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462607
16.
Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD.
Int J Chron Obstruct Pulmon Dis
; 15: 1935-1944, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32848379
17.
Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO®/DYNAGITO® Trials.
Adv Ther
; 37(10): 4266-4279, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776202
18.
The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD.
BMJ Open Respir Res
; 7(1)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268341
19.
Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics.
Respir Med
; 158: 97-109, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654891
20.
Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study.
Int J Chron Obstruct Pulmon Dis
; 13: 2147-2156, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30034230